A Stanford-led study found that most AI chatbots have stopped including medical disclaimers in health responses, raising ...

A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...

Artificial intelligence startup OpenEvidence banked a $210 million series B round as it looks to expand its strategic content ...

Microsoft's new model-agnostic MAI Diagnostic Orchestrator (MAI-DxO) achieved 85.5 percent diagnostic accuracy—outperforming ...

Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...

OpenEvidence, dubbed the 'ChatGPT for doctors,' uses AI to simplify evidence-based medical information for physicians, now ...

Once cautious, OpenAI, Grok, and others will now dive into giving unverified medical advice with virtually no disclaimers.

Isomorphic Labs, the AI -powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

OpenEvidence raises $210M on $3.5B valuation to expand AI-powered medical search and decision tools - SiliconANGLE ...

The Four Seasons Private Residences deal closed off-market — and the buyer made the purchase in cash for the fully furnished ...

It’s a sentiment felt widely across the medical field as AI starts to touch nearly every corner of medical research, physician training and processes, and patient care. The rollout of AI across health ...